Showing 111-120 of 3171 results for "".
Legalities of Injecting PDGF: Off-Label or Out-of-Bounds?
https://practicaldermatology.com/issues/october-2025/legalities-of-injecting-pdgf-off-label-or-out-of-bounds/39754/In medicine, science often moves faster than the rules designed to contain it do, and few debates illustrate this tension as starkly as the current one surrounding platelet-derived growth factor (PDGF) injections in aesthetic medicine.Aesthetic A-Peel: Using Peels in Practice
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aesthetic-a-peel-using-peels-in-practice/18556/As devices continue to evolve so do more "conventional" treatments, like peels. Dr. Gilbert talks about advancements in peels and the rise of nutraceuticals.Content Marketing
https://practicaldermatology.com/topics/practice-management/content-marketing/18316/Native advertising can help overcome shortcomings in your dermatology content distribution. This Ekwa Marketing video shows you how to do this.Analyzing IL-31 and the Benefits of Blocking It
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/analyzing-il-31-and-the-benefits-of-blocking-it/48777/James Q. Del Rosso, DO, FAOCD, discusses IL-31 and its involvement with itch, impairment of skin barrier function, and increased fibrosis of the skin.Psoriasis Comorbidities
https://practicaldermatology.com/topics/psoriasis/psoriasis-comorbidities/19729/Do you assess the gums of patients with psoriasis? Joel Gelfand, MD explains why periodontal disease may be underappreciated for what it contributes to the psoriatic disease process.Non-Biologics in Treatment and Management of Prurigo Nodularis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/non-biologics-in-treatment-and-management-of-prurigo-nodularis/48785/James Q. Del Rosso, DO, FAOCD, discusses the utility of topical therapies, cleansers, moisturizers, and phototherapy in treatment and management of prurigo nodularis.What’s New in Rosacea Treatments?
https://practicaldermatology.com/conferences/science-of-skin-summit-2025/tbd/39737/James Q. Del Rosso, DO, FAOCD, reviews the latest therapeutic innovations and evidence in rosacea management. This video was recorded at the Science of Skin Summit in Austin, TX.Nail Disease and JAK Inhibitor Safety
https://reachmd.com/programs/practical-dermatology/nail-disease-and-jak-inhibitor-safety/35897/Brad Glick, DO, talks about the basics of nail anatomy, physiology, disease presentation, and treatments, as well as the safety of JAK inhibitors, at Music City SCALE 2025.Risk In Your Portfolio
https://practicaldermatology.com/topics/practice-management/risk-in-your-portfolio/18588/Do you know your risk score? Physicians must understand their personal tolerance for risk as well as the level of risk in their current portfolios. If there is a mismatch, how do you rectify the disconnect. Bob Peelman, CFP, of OJM Group, explains. ABOUT THE AUTHORThe Biosimilar Revolution: A Look at the Potential Impact
https://practicaldermatology.com/issues/april-2025/the-biosimilar-revolution-a-look-at-the-potential-impact/35596/With many biosimilars expected to gain regulatory approval in coming months and years, Practical Dermatology interviewed Collin Blattner, DO, FAAD—an editorial board member and double-board–certified dermatologist who owns Clearchoice Dermatology, which has 12 locations in Oregon and Washington—abou